Protein A chromatography increases monoclonal antibody aggregation rate during subsequent low pH virus inactivation hold  by Mazzer, Alice R. et al.
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Protein  A  chromatography  is a near-ubiquitous  method  of mAb  capture  in  bioprocesses.  The  use  of low
pH buffer  for  elution  from  protein  A  is known  to contribute  to  product  aggregation.  Yet, a more  limited
set  of  evidence  suggests  that  low  pH  may  not  be  the  sole  cause  of  aggregation  in protein  A chromatogra-
phy,  rather,  other  facets of  the  process  may  contribute  signiﬁcantly.  This  paper  presents  a  well-deﬁned
method  for  investigating  this  problem.  An  IgG4  was  incubated  in elution  buffer  after  protein  A  chro-
matography  (typical  of  the viral  inactivation  hold)  and  the  quantity  of monomer  in  neutralised  samples
was  determined  by  size  exclusion  chromatography;  elution  buffers  of  different  pH  values  predeterminedgG
ize exclusion chromatography
fﬁnity adsorption
nfolding pH
to  induce  aggregation  of  the  IgG4  were  used.  Rate  constants  for monomer  decay  over time  were  deter-
mined  by ﬁtting  exponential  decay  functions  to  the data.  Similar  experiments  were  implemented  in  the
absence  of a chromatography  step,  i.e.  IgG4  aggregation  at low  pH.  Rate constants  for  aggregation  after
protein  A  chromatography  were  considerably  higher  than  those  from  low  pH exposure  alone;  a distinct
shift  in  aggregation  rates  was  apparent  across  the  pH range  tested.
© 2015  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license. Introduction
Therapeutic monoclonal antibodies (mAbs) occupy a signiﬁ-
ant portion of the biopharmaceutical market; 29 new mAbs are
resently undergoing late-stage clinical trials, including human
nd humanised IgG1, 2 and 4 molecules, amongst others [1].
ndustrial-scale production of biopharmaceuticals is a challenging
ask; preserving the product by limiting stresses that may  cause
egradation, combined with maximising yield and minimising
esources consumed are key elements of bioprocess development.
ne form of protein degradation is aggregation. In the biopharma-
eutical industry, aggregates are classed as impurities and must be
leared to acceptable levels if a protein formulation is to be used
herapeutically. Aggregates are thought to pose a risk of unwanted
mmunogenicity, and may  affect product potency and reproducibil-
ty [2–5].
After the initial product recovery stages of a bioprocess, the
capture” stage takes place, whereby substantial puriﬁcation and
oncentration of the product is effected in a single step [6]. A
ear-ubiquitous method of IgG capture is protein A afﬁnity chro-
atography. Staphylococcal protein A binds all IgG molecules of
∗ Corresponding author. Tel.: +44 20 76799580.
E-mail address: d.bracewell@ucl.ac.uk (D.G. Bracewell).
ttp://dx.doi.org/10.1016/j.chroma.2015.08.068
021-9673/© 2015 The Authors. Published by Elsevier B.V. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
subclasses 1, 2 and 4 [7] with high selectivity and minimal interac-
tion with the Fab region [8], the active region of the drug molecule.
Product molecules are eluted from protein A resins by lowering the
pH; a typical elution buffer is 0.1 M sodium citrate, pH 3.3. Low pH is
often maintained for a period of time for the purpose of viral inacti-
vation [9,10]. However, for many antibodies, acidic conditions and
sudden pH changes can result in aggregation [3,7,9–11].
Protein aggregation induced by pH has been the subject of much
investigation in bioprocess development, and low pH is typically
cited as the cause of product aggregation occurring during or after
protein A [12] chromatography; it is also acknowledged that pro-
tein aggregation often occurs more readily at high concentrations.
Further to this, a more limited pool of evidence suggests that low pH
may  not be the sole cause of aggregation in protein A chromatogra-
phy, rather, the adsorption and desorption events themselves may
contribute signiﬁcantly [6,9,13].
A typical model for protein aggregation consists of four stages:
reversible destabilisation of native structure or partial unfolding to
form the “reactive monomer” (RM) [14]; reversible or irreversible
association of RM yielding a more thermodynamically favourable
“aggregate” state; association of a critical number of RM to form
a nucleus; addition of RM or small oligomers to the nucleus to
form larger amorphous or ordered aggregates [14]. Different the-
ories argue different stages as the rate limiting step [2,14]. For
the ﬁrst stage, the destabilising effect of low pH on IgG4 has been
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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hown using differential scanning calorimetry (DSC), a method for
ssessing thermal unfolding. At pH 6.0, two major endothermic
ransitions are seen; at pH 3.5 similar transitions are seen at sig-
iﬁcantly lower temperatures; at pH 2.7 a very different transition
roﬁle is seen, with major transitions occurring at relatively low
emperatures [10].
A study by Shukla et al. attempted to elucidate the collective
ffects of low pH, protein concentration and chromatographic sep-
ration on an Fc-fusion protein [9]. Shukla et al. found that protein
 chromatography signiﬁcantly increased the rate constant for for-
ation of high molecular weight species at low pH. Rate constants
ere determined graphically using a derivation of a Lumry–Eyring-
ased kinetic model for monomer loss/aggregate formation. In
his instance rate constants were found to be concentration-
ndependent. Different additives included in the chromatography
lution buffer signiﬁcantly altered aggregation rates. Interestingly,
n some cases, additives that stabilised proteins at low pH in solu-
ion had destabilising effects in chromatography experiments. Urea
as an effective additive in reducing on-column and in-solution
ggregation at concentrations of 0.5 M and 1 M,  respectively [9].
n other work, arginine was found to prevent protein aggrega-
ion on elution from protein A [6]. Recent work by Gagnon et al.
howed that elution from protein A affects the conformation of
gG1; namely, a signiﬁcantly reduced hydrodynamic radius and
hanges in secondary structure content were observed. Notably
hese effects did not occur at low pH in the absence of the elution
vent [13].
Protein A binds to the Fc region of IgG about the hinge between
he CH2 and CH3 domains; it contains ﬁve highly-homologous
c-binding domains and can bind at least two IgG molecules simul-
aneously [15–18]. The precise region of the Fc that binds to
rotein A can also bind a number of other molecules; thus, it has
een termed consensus binding site (CBS) [19]. The CBS is largely
ydrophobic in character, contains relatively few polar residues
nd has a high level of solvent accessibility. These features indi-
ate burial of hydrophobic residues as a strong driver of binding
19,20]. Electrostatic interactions [8] and hydrogen bonds at cer-
ain highly conserved sites [21] have also been indicated in binding.
ccording to Delano et al., the CBS undergoes considerable confor-
ational changes when binding to a ligand. In fact, the nature of
he change in conformation depends on the ligand, highlighting
he ﬂexibility of this region [19]. Though ﬂexibility implies good
tructural recovery after conformational change, under antagonis-
ic conditions such as low pH there may  be greater vulnerability
o detrimental levels of structural alteration. X-ray crystallography
tudies by Deisenhofer found that CH2 domain disorder was  greater
n an Fc-Fragment B complex (Fragment B being a single protein
 domain) than in the unbound Fc, implying potential Fc desta-
ilisation on adsorption to protein A [13,20]. However, this may
ot have been the case had the Fab fragment been present, due to
H2-Fab contact [20]. Conversely, it has been shown that some IgG
olecules retain a folded structure at pH conditions as low as pH
.7 after elution from a protein A column, though it is not identi-
al to the native structure. In this case, IgG aggregation after low
H elution was instead attributed to conformational disturbances
ccurring during neutralisation of low pH samples [10].
Predictably, the literature indicates great variation in protein
ggregation behaviour depending on the protein. Though aggrega-
ion in protein A elution pools is well-acknowledged, its mechanism
nd impact is not well-understood. The aim of this work is to clearly
resent a method showing that the process of protein A chromatog-
aphy increases the rate of aggregation of an IgG4 molecule at low
H. Experiments are designed to mimic  the part of a standard mAb
ioprocess where protein A chromatography is followed by incuba-
ion at low pH for the purpose of virus inactivation, and subsequent
eutralisation of this pool. MabSelect Xtra (GE Healthcare), whichgr. A 1415 (2015) 83–90
consists of agarose particles with an engineered recombinant pro-
tein A ligand, will be used as this is a modern industrially relevant
resin. Importance is placed on production of reliable kinetic data
and strong comparability between data sets where a chromatogra-
phy step is included, and those done in solution only at low pH.
2. Materials and methods
2.1. Materials
The IgG molecule used for all experiments was kindly donated
by UCB Celltech (UCB Celltech, Slough, UK). It is a puriﬁed IgG4
kappa antibody; the hinge region is not mutated. The IgG is for-
mulated at 17.8 mg/mL in 270 mM glycine, 1% maltose, pH 5.0. This
IgG4 kappa has a PI between 6.85 and 8.15.
2.2. Equipment
Size exclusion chromatography (SEC) was carried out using an
Agilent 1100 HPLC system with ChemStation software (Agilent
Technologies UK Ltd., Berkshire, UK) with a TSK Gel 7 mm × 300 mm
G3000SWXL column (Tosoh Bioscience LLC, Montgomeryville,
USA). Afﬁnity chromatography was carried out using an AKTA
Avant 25 liquid chromatography system with Unicorn 6 software
(GE Healthcare, Uppsala, Sweden), with a 1 mL HiTrap MabSe-
lect Xtra column (GE Healthcare UK Ltd., Buckinghamshire, UK)
attached.
2.3. Methods
2.3.1. Solution experiments
Solution experiments were carried out initially to determine
an appropriate pH range to work in with this IgG4 molecule, and
timescales for aggregation.
The IgG was mixed with various solutions of glycine–HCl to pro-
duce solutions of IgG at concentrations ranging from 0.9 mg/mL
to 4.5 mg/mL, pH conditions ranging from pH 2.78 to pH 3.03,
and a buffer concentration of 0.15 M glycine–HCl. Proportions of
reagents needed to give the desired pH were calculated using
the Henderson–Hasselbalch equation with an adjustment for ﬁxed
ionic strength [22]. pH was measured using a standard laboratory
pH probe; pH adjustment was  not implemented and reported pH
values represent the measured values. Concentrations recorded are
calculated values based on the initial concentration reported for
the drug substance and the subsequent level of dilution in low
pH buffer. Samples were taken from each solution at various time
points and neutralised with a 10% volume of 0.8 M Tris–HCl, pH
8.45. Neutralised samples were diluted in SEC mobile phase buffer.
Samples were stored at 4 ◦C overnight before analysis by SEC. All
conditions were run in duplicate. Controls consisted of IgG4 diluted
to various concentrations in SEC buffer and run on the SEC column.
The order of analysis of all samples (including controls) by SEC was
randomised. Peaks were detected by absorbance at 280 nm. The
following equation was used to determine percentage monomer
recovered:
R =
(
AS
AC
)
× 100 (1)
where R is the percentage monomer recovered, and AS and AC are
the sample and control monomer peak areas (mAU2), respectively.
Percentage monomer recovered was plotted against incubation
time to determine rate of monomer loss.2.3.2. Column experiments
A 1 mL  HiTrap MabSelect Xtra column was  equilibrated with 3
column volumes (CV) 0.02 M sodium phosphate, pH 6.7, and 2 mL
matogr. A 1415 (2015) 83–90 85
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Fig. 1. Schematic of experimental design where incubation at low pH follows pro-
tein A chromatography (a). Incubation is assumed to begin when the elution peak
begins, denoted t0. Fractions containing approximately the ﬁrst two thirds of the
elution peak were at pH conditions considerably higher than the elution buffer pH.
IgG concentration and pH in fraction 3 were the conditions reproduced in solution
experiments for comparability with column experiments. A precise representation
of  the experimental outcome can be seen in (b), a chromatogram from a protein A
chromatography run. The solid line (left y-axis) represents the IgG elution peak and
the dotted line (right y-axis) indicates the pH of column efﬂuent, as measured by
the  in-line pH probe. Here, ﬂow of elution buffer begins at 7 mL elution volume. TheA.R. Mazzer et al. / J. Chro
f 5.6 mg/mL  IgG4 was loaded onto the column using a sample loop.
he column was washed with 3CV (sufﬁcient to return baseline to
ero) 0.02 M sodium phosphate, pH 6.7, and step elution of the pro-
ein was effected with 5CV 0.15 M glycine–HCl, pH 2.93. The column
fﬂuent was monitored by absorbance at 280 nm and 0.5 mL  frac-
ions were collected throughout elution. The delay volume between
he detector and the fraction collector on the AKTA system was
94 L. Protein concentration in each fraction was measured ofﬂine
nd showed that fraction location was consistent with the UV trace
rom the AKTA software. The pH was monitored using the in-line
H metre supplied with the AKTA instrument which was  calibrated
or the elution pH range (between pH 1.68 and pH 4.00); in-line
H measurement was used only as an indicative measure before
fﬂine measurement of individual fractions. The majority of the
lution peak was collected into three central fractions. The third of
hese fractions, containing the tail end of the peak, was  used for
ubsequent experimentation as this fraction was  at an appropri-
te pH to induce aggregation. This will be referred to as fraction 3.
raction 3 was mixed to ensure homogeneity and incubated at the
lution pH. The pH of all elution fractions was veriﬁed at the end of
he incubation using a PHR 146B Micro Combination pH Electrode
Lazar Research Laboratories, Los Angeles, CA, USA). Chromatogra-
hy “dry runs” were also carried out in the absence of IgG and the
H of the elution fractions were measured individually. Fraction
 was found to be at the pH of the original elution buffer, ±0.03
H units. Samples of fraction 3 were neutralised at various time
oints, then diluted in SEC mobile phase buffer and stored overnight
efore SEC analysis as in Section 2.3.1. The protein concentration
n these samples was determined by measuring the absorbance of
ach sample at 280 nm using a NanoDrop 1000 spectrophotometer
Thermo Scientiﬁc, Wilmington, DE, USA), and using Beer’s law and
n extinction coefﬁcient E0.1%1 cm = 1.61 (experimentally determined
y UCB Celltech, Slough). Control samples, for calculation of per-
entage monomer loss, consisted of the column feed (IgG diluted
n equilibration buffer), the concentration of which was also veri-
ed by UV absorbance measurement. Controls for “effect of column
lone” consisted of samples from the leading side of the elution
eak; on exiting the protein A column, these samples were not at
 pH low enough to induce aggregation, this was conﬁrmed by SEC
nalysis.
.3.3. Size exclusion chromatography
0.1 M sodium phosphate, 276 mM NaCl, pH 6.3 was used as the
obile phase buffer for SEC. The ﬂow rate was 1 mL/min and the
njection volume was 20 L. Peaks were detected by absorbance
t 280 nm.  Before injection onto the SEC column all samples were
pun at 13,000 rpm to remove any precipitated protein material.
.3.4. Data analysis
Statistical analysis and data ﬁtting were carried out using
riginLab® OriginPro 9.0 software.
. Results and discussion
.1. Experimental design
Initial experiments were done in solution under a range of low
H conditions and IgG4 concentrations in order to determine the
asic behaviour of the mAb  at low pH and identify a useful pH
ange to work in. Typical conditions and time-courses for protein
 chromatography and virus inactivation at low pH were taken
nto account. Time-consumption and reproducibility of experi-
ents was also considered. Additionally, the formulation buffer of
he puriﬁed mAb  contributed to experimental design decisions; as
he formulation buffer already contained a high concentration of
lycine (0.27 M),  glycine–HCl buffers were used to lower the pHlast two fractions of the elution peak, indicated within vertical lines in (b), were at
pH  conditions low enough to induce aggregation.
in solution experiments, and for product elution in column exper-
iments. Glycine–HCl is often used as an afﬁnity chromatography
elution buffer, though citrate or acetate buffers are more com-
mon in bioprocessing when a slightly higher elution pH is required
[23–26]. In the case of this work, using glycine–HCl reduced the
number of sample manipulation steps and potential confounding
effects this might have on aggregation data. The pH range chosen
for experiments covers a larger range than would usually be con-
sidered for industrial puriﬁcation [6,7,9,10,21], as it is required to
plot correlations between aggregation rates and low pH. Column
experiments were carried out as shown in Fig. 1. Incubation at the
elution pH was assumed to begin at the ﬁrst sign of the elution
peak (increase in absorbance at 280 nm), denoted t0 in Fig. 1a. It
is assumed that the mAb  has been exposed to the elution buffer at
this stage. The column efﬂuent does not approach pH 3 until the tail
end of the peak, i.e. Fraction 3, but marking t0 earlier eliminates the
possibility of exaggerating the column effect on aggregation rate.
The IgG4 concentration in Fraction 3 (Fig. 1b) was within the range
tested in solution, supporting comparability between in-solution
and on-column data.Size exclusion chromatography was  used to quantify IgG
monomer and high molecular weight (HMW) species in the test
samples. Monomer loss over time was  chosen as the basis for
86 A.R. Mazzer et al. / J. Chromato
Fig. 2. SEC chromatograms for IgG4 incubated under a range of low pH condi-
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ith 12 mg  IgG. Bottom: pH 2.92 after elution from column loaded with 25 mg  IgG.
egends show incubation times to the nearest minute.
uantiﬁcation of aggregation rates. Under all sufﬁciently harsh
onditions tested, monomers were partially converted to a range
f high molecular weight species over time as can be seen in
ig. 2. A few major observations were made. Firstly, regardless
f (perceived) harshness of conditions, with sufﬁcient time, incu-
ation at low pH resulted in an increasing front shoulder to the
onomer peak and a small shift of the whole peak in the direc-
ion of shorter elution time. This is indicative of a monomer either
ith increased molecular weight, or with altered physical char-
cter that could accelerate its transit through the SEC column [5].
arsher conditions and/or longer incubation times instigated these
hanges in the monomer peak. The pronounced front shoulder on
he monomer peak (Fig. 2, top) may  represent an individual popula-
ion of monomer in a molten globule state [27]. Alternatively, it may
e due to an oxidised species such as the oxidised tryptophan IgG2gr. A 1415 (2015) 83–90
monomer “pre-peak” species characterised by Wong et al. [28].
Another observation was  that decrease in monomer peak area was
proportional to increase in HMW  species peak area, up to a point.
After this point, (see top and middle plots in Fig. 2), the peak area
for HMW  species did not increase and the monomer front shoul-
der developed further; in the bottom plot (Fig. 2) the monomer
peak continued to decline without either signiﬁcant development
of the monomer front shoulder or an increase in HMW species.
These results indicate that aggregates whose molecular weights
exceed the exclusion limit of the SEC column may  form to varying
extents depending on the conditions. Such species may  have been
retained inside the column or HPLC system, or been removed by
centrifugation prior to sample injection onto the column.
Overall, it was concluded that reduction in monomer peak area
as determined by SEC provided an accurate measure of aggrega-
tion rate. In cases of long or harsh incubation, the leading shoulder
developing on the monomer peak was  counted as normal monomer
when plotting the data; the implications of this are discussed in
Section 3.3.1.
3.2. Rate of monomer loss at low pH in solution
The IgG4 was found to be highly sensitive to pH within a critical
range. At pH conditions lower than pH 2.8 aggregation was  rapid;
plateau occurred in less than 30 min. However, at pH > 3.0 comple-
tion took approximately 4 h. It should be noted that the plateau
was not found at the point of complete monomer loss, and var-
ied depending on pH conditions; lower pH conditions resulted in
greater total monomer loss (Fig. 3). It is possible that what appears
as a plateau in monomer depletion actually represents a point of
reversible equilibrium between species at one or more stages of
the aggregation process. An ancillary experiment was carried out
in which monomer puriﬁed from initial aggregation runs was re-
exposed to low pH under the same conditions as in the initial runs.
Recovered monomer was  found to display near-identical aggrega-
tion behaviour to initial monomer (data not shown). This indicates
that the surviving monomer population is not distinct from the
aggregating portion, supporting the possibility of an equilibrium
mechanism. Despite the fairly large IgG concentration range tested
(ﬁve-fold), concentration appeared to have little effect on aggre-
gation kinetics, and observed differences in plateau did not follow
a clear trend. Thus we hypothesise that aggregation plateau was
determined by pH-dependent equilibrium between unfolded and
native or re-folded monomers. While this could provide an interest-
ing topic for more detailed investigation, it will not be the focus of
this study. Instead, we concentrate primarily on initial aggregation
rates as well as apparent total monomer loss.
All data sets were ﬁtted with exponential decay curves using the
following equation:
y = y0 + A.e−R0.x (2)
where y0 is the plateau point (total monomer remaining), A is the
initial value (total monomer lost), R0 is the rate constant (h−1) and
x is incubation time (h).
The value of interest resulting from ﬁtting curves to the data is
the rate constant, R0. The rate constant provides a convenient com-
parator for chromatography experiments, similarly to that used by
Shukla et al. [9]. Rate constants varied most with pH, while IgG4
concentration had a limited effect on R0 values, within the concen-
tration range tested, as seen in Fig. 4. To verify concentration effect,
or lack thereof, R0 was  plotted against pH for the three IgG concen-
trations tested and linear regression with 95% conﬁdence limits was
applied to each data set. There were few data points at 0.9 mg/mL
so this data set was not ﬁtted. Conﬁdence intervals of the linear ﬁts
for 2.7 mg/mL  and 4.5 mg/mL  overlapped, indicating that IgG con-
centration did not signiﬁcantly affect R0 in solution (Fig. 4). This is
A.R. Mazzer et al. / J. Chromatogr. A 1415 (2015) 83–90 87
Fig. 3. IgG monomer loss over time in solution at (a) 0.9 mg/mL, (b) 2.7 mg/mL  and
(c)  4.5 mg/mL. Different symbols represent different incubation pH conditions: cir-
cles, pH 3.03; open squares, pH 2.95; ﬁlled squares, pH 2.78. Error bars show the
standard deviation for each point based on full experimental repeats, n = 2. Expo-
nential decay curves were ﬁtted to the data using the equation y = y0 + AeR0 .x (see
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Fig. 4. Semi-log plot of monomer decay rate, R0, against pH in solution at three dif-
ferent IgG concentrations. Y-error bars show the standard error for the R0 parameter
(Eq. (2)) obtained from least squares ﬁtting; x-error bars represent pH measurementection 3.2 for equation speciﬁcs). In (a), for pH 2.78 the last time point (2.18 h) was
xcluded from the curve ﬁt (see Section 3.3.1). All ﬁts were signiﬁcant with adjusted
2 > 0.99 and P < 0.01.
seful in terms of allowing some ﬂexibility in IgG concentration for
olumn experiments, as elution fractions may  not be of precisely
he same concentration for every run.
.2.1. Negligible effect of maltose
Maltose has been known to stabilise proteins and reduce aggre-
ate formation [17]. The IgG4 initial formulation contained 1%
altose; subsequently, low concentrations of maltose were presentn solution experiments (0.05–0.25%). Maltose was not added to
lution buffers for column experiments so was not present during
hose incubations. Thus it was necessary to conﬁrm that maltose
as not reducing aggregation rates in solution. Additional solutionerror. Linear regression was  applied for concentrations 2.7 mg/mL and 4.5 mg/mL;
for clarity, 95% conﬁdence intervals only are shown for these ﬁts. A trend has not
been ﬁtted to the 0.9 mg/mL data because there are few data points.
experiments were carried out at pH 2.90 with maltose at concen-
trations from 0.15% to 4.0%, and 2.7 mg/mL  IgG4. Maltose had no
signiﬁcant effect on IgG aggregation rate in these experiments (data
not shown). Low maltose concentrations (0.25–1.5%) also had no
discernible effect in solution from 0.9 to 4.5 mg/mL IgG4, pH 3.0
(data not shown). Subsequently, maltose was not added to protein
A elution buffers.
3.3. Effect of column step on rate of monomer loss at low pH
In Fig. 5a–c monomer loss over time under various pH conditions
is plotted for column and solution experiments side by side. All
column experiment data was ﬁtted with exponential decay curves
as was  done for solution data. Fig. 5d shows all column experi-
ment curves side by side on a single unbroken scale. Examining the
plots in Fig. 5, the initial rate of monomer consumption and the
position and behaviour of the plateau can be compared for the dif-
ferent test conditions. Due to the sharp drop-off in pH sensitivity
between pH 2.7 and pH 3.0, the data in Fig. 5a–c is displayed in
three narrow ranges: pH 2.78–2.86 (a), pH 2.90–2.95 (b) and pH
3.03–3.11 (c). Note that the x-axis scales differ for each plot and
also contain scale breaks. The pH values indicate the pH at which
the IgG was  incubated after elution from the column, which was  the
same as the pH of the original elution buffer. In all cases, inclusion
of the protein A chromatography step immediately before incuba-
tion resulted in a faster rate of monomer decay at any given pH.
Exponential decay kinetics to a point of apparent equilibrium was
maintained in column experiments as in solution. This suggests that
the chromatography step does not signiﬁcantly change the basic
aggregation mechanism, but does accelerate it.
3.3.1. Monomer leading shoulder
As can be seen largely in Fig. 3 and Fig. 5, though a general
plateau was  reached in all experiments, it was not completely
stable. In some cases (typically the harsher conditions) monomer
concentration appeared to drift up again. This may  be explained
by the apparent formation of an altered monomer species, as seen
in Fig. 2. The (extra) area contributed by this peak shoulder was
counted as normal monomer in “% Monomer” calculations (see Sec-
tion 2.3.1). Excluding the shoulder area would result in stabilisation
of % Monomer values at the plateau, rather than upward drift up.
On the other hand, whether the monomer shoulder species should
be considered a precursor to the aggregated form, or even one of
its break-down products, is contestable [27]. Thus, data points that
88 A.R. Mazzer et al. / J. Chromatogr. A 1415 (2015) 83–90
Fig. 5. Rates of monomer loss at 2.7 mg/mL  IgG under different pH conditions in solution only (ﬁlled symbols and solid lines) and after elution from a protein A chromatography
c  are shown in the plot legends. Curves for column runs across the full pH range are shown
t n full experimental repeats, n = 2. All data sets were ﬁtted with exponential decay curves
a  0.98 and P < 0.01.
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Fig. 6. Y0 (plateau point parameter) from exponential decay curve ﬁts plotted
against pH at 0.9 mg/mL, 2.7 mg/mL and 4.5 mg/mL in solution, and at approximately
2.7 mg/mL  after protein A chromatography. Y-error bars show the standard error for
the  Y0 parameter (Eq. (2)) obtained from least squares ﬁtting; x-error bars repre-
sent pH measurement error. The data was pooled and ﬁtted with a linear trendolumn (open symbols, dashed lines and dotted lines) (a–c). Different pH conditions
ogether in (d). Error bars show the standard deviation for each time point based o
s  was done for initial solution only data. All ﬁts were signiﬁcant with adjusted r2 >
rift up after the plateau were counted as “normal” for the pur-
ose of curve ﬁtting unless the ﬁt was rejected by the software (see
ig. 3a, pH 2.78). Nonetheless, it is worth noting that the shoulder
ay  represent a degraded form of the product whose bioactivity
iffers from that of the native monomer [28]; this could provide an
nteresting subject for further investigation. In other cases, after a
eriod of stability monomer concentration began to drop (Fig. 5c),
his is discussed below.
In column experiments the shoulder developed to a similar
xtent but more quickly than in solution experiments, supporting
he model of acceleration of the mechanism of aggregation when
he chromatography step was present.
.3.2. Variation in monomer plateau
Within the lowest pH range, pH 2.78–2.86, the monomer plateau
onsistently fell between 40% and 45% of the initial concentration
or both solution and column experiments (Fig. 5a and d). Within
he highest pH range, pH 3.03–3.11, plateau points were similar for
ear-matching pH conditions (e.g. solution pH 3.03 versus column
H 3.05). The trend of reduced total monomer loss with increasing
H was matched by the column experiment data at pH 3.11, all in
ll the highest pH tested, with the plateau being at the highest per-
entage monomer compared to all other test conditions. For the pH
.11 column experiment a slow linear drop in monomer continues
etween 4 h and 24 h, meaning that exponential decay may  not be
he best ﬁt available for the data in this region and a different mech-
nism of aggregation may  prevail. For the purpose of this study, an
xponential decay ﬁt was used as it described the initial period of
apid monomer loss well, giving an adjusted r2 value of 0.985 with
igniﬁcance P < 0.01 for pH 3.11 (Fig. 5). It is possible that above a
ertain pH, or even after a certain duration, the system transitions
o a different kinetic mechanism.
In other cases upward drift in the plateau occurred, but this can
argely be attributed to the presence of monomer leading shoulder
pecies described above.(solid line); error weighting was not used for the ﬁtting. The 95% conﬁdence inter-
val  is shown as dotted lines. The ﬁt was  signiﬁcant with an adjusted r2 of 0.75 and
P  < 0.01.
In summary, the plateau point was  not considered a robust
parameter to quantify the aggregation that occurred under the
given conditions. This is further illustrated in Fig. 6, where the
relationship between pH, y0 values and IgG concentration for
solution-only and column experiments is displayed. The general
trend of decreasing monomer loss with increasing pH can be seen,
and it is also apparent that the effects of IgG concentration and the
column step on y0 are not well deﬁned.3.3.3. Inﬂuence of column step on R0
Focussing on the initial period of rapid monomer loss under
the various conditions displayed in Fig. 5, it can be seen that the
A.R. Mazzer et al. / J. Chromato
Fig. 7. Semi-log plot of monomer decay rate, R0, against pH for solution-only exper-
iments (ﬁlled triangles) and experiments including a protein A chromatography
step (open circles). For column experiments, the typical concentration of the incu-
bated elution fraction was  2.7 mg/mL. Solution-only data seen in Fig. 4 was  pooled
due to overlapping 95% conﬁdence intervals for the linear trends. For solution-only
data points, x error bars represent the measurement error of the laboratory pH
probe/metre, as reported by the manufacturer. For chromatography experiments,
x  error bars correspond to measured error based on three replicate measurements
(with a micro pH probe). For both solution-only and column experiments, y error
bars represent the standard error for the R0 parameter (Eq. (2)) obtained from least
squares ﬁtting. A linear trend was  ﬁtted to each data set, as shown by solid lines;
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oashed/dotted lines represent 95% conﬁdence limits for each ﬁt. Both ﬁts were sig-
iﬁcant with P < 0.01 and adjusted r2 of 0.97 and 0.90 for solution-only and column
xperiments, respectively.
olumn step had a considerable effect on the rate at which
onomers were converted to aggregate species during the low pH
old. Looking at Fig. 5b, between pH 2.90 and pH 2.95 it is clear
hat that rate of monomer loss is fastest for the column experi-
ent. Comparing pH 3.03 solution data to pH 3.11 column data
Fig. 5c), the initial decline in monomer progresses at a similar rate
or both experiments; this is signiﬁcant considering the extreme
H sensitivity of the system.
Fig. 5 allows the kinetics of individual cases to be assessed and
ompared. Due to the pH sensitive nature of the experiments, direct
omparison of column and solution data is difﬁcult because of
mall differences in pH. Individual ﬁtted parameters, R0 and y0,
ere plotted against pH to more clearly delineate the effect of the
hromatography step.
Fig. 7 illustrates how the protein A chromatography step causes
 shift in the rate of monomer loss compared to low pH incubation
lone. It is clear that two separate trends exist for R0 against pH
or solution-only and on-column experiments. In Fig. 7, 95% con-
dence bands were calculated using the standard error for the R0
arameter (obtained from least squares ﬁtting) for weighting. The
inear ﬁt lines for column and solution-only R0 values are almost
arallel; this supports the theory that the aggregation mechanism
s accelerated, but not signiﬁcantly altered, by the chromatography
tep. The data represents the minimum difference between after-
olumn and solution-only rates, in that the earliest reasonable start
ime for low pH incubation was used for column experiments (see
ection 3.1).
It should be noted that the y axis in Fig. 7 is scaled logarithmi-
ally; what appears as a linear ﬁt is actually exponential. This is of
nterest as it shows how the data collected is centred on a tipping
oint for aggregation behaviour of the IgG4; two  orders of magni-
ude in aggregation rate are covered in approximately 0.3 pH units.
utside the range of conditions tested aggregation becomes either
nacceptably rapid, or slow to the point of practical insigniﬁcance
in the context of an early/mid puriﬁcation process). It is important
o consider that the column step has an effect despite the narrow
ange in which it was possible to quantify effects using the meth-
ds described. In effect, the column step seems to push the tippinggr. A 1415 (2015) 83–90 89
point in the direction of milder conditions. A related result was  seen
by Gagnon et al. for an IgG1. They found that adjusting to pH 3.0
after elution from protein A (at pH 3.5) resulted in considerable
aggregate formation which was not observed in the absence of the
chromatography step. It was  concluded that elution from protein A
increased the protein’s “vulnerability” to a secondary stress, such
as pH [13].
4. Conclusion
The data we have gathered captures the behaviour of an IgG4
within a fairly compact experimental space. The IgG4 demonstrates
highly pH-dependent and apparently concentration-independent
aggregation behaviour. Given these observations, we hypothesise
that the aggregation behaviour is governed predominantly by a
pH-dependent unfolding/re-folding equilibrium. Our data shows
that the chromatography step causes aggregation rates to increase,
while other aspects of the aggregation kinetics appear largely
un-affected. One possible molecular mechanism is that the con-
formational change, as well as changes in the hydration layer
around the protein, required for protein adsorption and subsequent
desorption, alter the structure of the IgG, possibly exposing regions
of the protein involved in unfolding transitions. Being in this condi-
tion, immediate exposure to the acidic environment could increase
the possibility of the protein unfolding and losing native structure
to some extent before progression to aggregate formation during
the pH hold [13,27,29].
It should also be considered that only the tail end of the pro-
tein A elution peak was assessed in this work, as all prior efﬂuent
was at a pH too high to induce aggregation. The peak tail may
represent a monomer sub-population with a higher afﬁnity for
the ligand. It is possible that these monomers bind more-tightly
than early-eluting species, undergo increased structural perturba-
tion during adsorption and desorption, and are thus more likely to
aggregate, increasing the rate. This type of phenomenon, whereby a
strongly bound sub-population was  generated, has been described
previously and investigated in detail for hydrophobic interaction
chromatography [30,31]. Heterogeneity in recombinant protein
products is commonly documented, with species raging from dis-
tinct charge variants to product molecules with a single erroneous
amino acid substitution [32]. A future extension of this work could
investigate heterogeneity across the elution peak, and subsequent
effects on aggregation behaviour.
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